MedTrace Logo

Research and Characterization of New Genes Involved in Intellectual Disability

NCT01867554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8500

Last updated 2025-01-23

No results posted yet for this study

Summary

Intellectual disability (ID) occurs in 2 to 3 % of the general population but the cause is identified only in 30 to 60% of cases.

The purpose of this study is to indentify genes involved in ID with new genetics tools (SNP-arrays, next generation sequencing...) and establish genotype-phenotype correlations.

Conditions

  • Intellectual Disability

Interventions

GENETIC

gene analysis

gene analysis

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Alexis Brice, MD · Institut National de la Santé Et de la Recherche Médicale, France

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01867554 on ClinicalTrials.gov